Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01682083
Brief Title: Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD). (COMBI-AD)

First Submitted : September 6, 2012
First Submitted that Met QC Criteria : September 7, 2012
First Posted : September 10, 2012 (Estimate)

Results First Submitted : May 29, 2018
Results First Submitted that Met QC Criteria : August 28, 2018
Results First Posted : September 26, 2018

Certification/Extension First Submitted : March 30, 2018
Certification/Extension First Submitted that Met QC Criteria : March 30, 2018
Certification/Extension First Posted : April 3, 2018

Last Update Submitted that Met QC Criteria : August 29, 2019
Last Update Posted : September 10, 2019